Product Code: ETC4746711 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The Mozambique Influenza Vaccine Market is poised for steady growth rate improvements from 2025 to 2029. Commencing at 9.90% in 2025, growth builds up to 20.88% by 2029.
By 2027, Mozambique's Influenza Vaccine market is forecasted to achieve a exponential growth rate of 16.85%, with Egypt leading the Africa region, followed by South Africa, Ethiopia, Algeria and Nigeria.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mozambique Influenza Vaccine Market Overview |
3.1 Mozambique Country Macro Economic Indicators |
3.2 Mozambique Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Mozambique Influenza Vaccine Market - Industry Life Cycle |
3.4 Mozambique Influenza Vaccine Market - Porter's Five Forces |
3.5 Mozambique Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Mozambique Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Mozambique Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Mozambique Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Mozambique Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Mozambique Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mozambique Influenza Vaccine Market Trends |
6 Mozambique Influenza Vaccine Market Segmentations |
6.1 Mozambique Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Mozambique Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Mozambique Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Mozambique Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Mozambique Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Mozambique Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Mozambique Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Mozambique Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Mozambique Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Mozambique Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Mozambique Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Mozambique Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Mozambique Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Mozambique Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Mozambique Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Mozambique Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Mozambique Influenza Vaccine Market Export to Major Countries |
7.2 Mozambique Influenza Vaccine Market Imports from Major Countries |
8 Mozambique Influenza Vaccine Market Key Performance Indicators |
9 Mozambique Influenza Vaccine Market - Opportunity Assessment |
9.1 Mozambique Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Mozambique Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Mozambique Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Mozambique Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Mozambique Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Mozambique Influenza Vaccine Market - Competitive Landscape |
10.1 Mozambique Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Mozambique Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |